- Home
- IAUX vs AMLX Comparison
IAUX vs AMLX Comparison
Compare IAUX & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$12.01
Company Overview
Basic Information| Metric | IAUX | AMLX |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | IAUX | AMLX |
|---|---|---|
| Price | $1.46 | $12.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $1.50 | ★ $17.43 |
| AVG Volume (30 Days) | ★ 7.8M | 1.5M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $97,131,000.00 | N/A |
| Revenue This Year | $85.81 | N/A |
| Revenue Next Year | $97.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 83.46 | N/A |
| 52 Week Low | $0.48 | $2.60 |
| 52 Week High | $1.60 | $16.96 |
Technical Indicators
Market Signals| Indicator | IAUX | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 59.60 | 37.95 |
| Support Level | $1.43 | $11.69 |
| Resistance Level | $1.59 | $12.80 |
| Average True Range (ATR) | 0.09 | 0.59 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 43.75 | 20.29 |
Price Performance
Historical Comparison IAUX
AMLX
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.